K. Karamperis

Toward High-Throughput Fungal Electroculturomics and New Omics Methodologies in 21st-Century Microbiology and Ecology.

C. Anastassopoulou, G. Patrinos, A. Velegraki, 2020, Omics : a journal of integrative biology.

Economic evaluation in psychiatric pharmacogenomics: a systematic review

P. Papantoniou, G. Patrinos, D. Müller, 2021, The Pharmacogenomics Journal.

Beyond the Microbiome: Germ-ganism? An Integrative Idea for Microbial Existence, Organization, Growth, Pathogenicity, and Therapeutics.

G. Patrinos, A. Velegraki, I. Giavasis, 2022, Omics : a journal of integrative biology.

Genome-based therapeutic interventions for β-type hemoglobinopathies

G. Patrinos, C. Moutinho, M. Koromina, 2021, Human Genomics.

Adoption of Pharmacogenomic Testing: A Marketing Perspective

G. Patrinos, K. Vasileiou, C. Mitropoulou, 2021, Frontiers in Pharmacology.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

Genetic Testing

G. Patrinos, M. Koromina, K. Karamperis, 2020, Definitions.

Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.

G. Patrinos, T. Katsila, A. Symeonidis, 2019, Pharmacogenomics.

Costing Methods as a Means to Measure the Costs of Pharmacogenomics Testing.

Christina Mitropoulou, George P Patrinos, Stavroula Siamoglou, 2020, The journal of applied laboratory medicine.

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

G. Patrinos, K. Vasileiou, J. Swen, 2023, Human Genomics.